Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlookJanuary 30, 2025
Tron, Tether, and TRM Labs Led Consortium Freezes $26.4M Linked to European Crime SyndicateJanuary 30, 2025
Market Trends Merck gets priority review for Welireg for PPGL (MRK:NYSE)By admin8996erT0allJanuary 27, 2025 Sundry PhotographyThe FDA has accepted Merck’s (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known…
